[1]
Aggarwal, D. et al. 2020. A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine. Kansas Journal of Medicine. 13, S2 (Feb. 2020), 2–5. DOI:https://doi.org/10.17161/kjm.v13i.13495.